7:00 -8.00 BOARDROOM
Meeting of the Board of the Invasive Cardiology journal.

7:30-8:50. ROOM RUBINSTEIN (second floor)
General Assembly of the Asspciation on Cardiovascular Interventions of the Polish Cardiac Society.

9:00-11:05 ROOM C
Forum on Acute Coronary Syndromes: A patient with NSTE-ACS. New guidelines and real life cases.
Chairmen: Robert J. Gil (Warsaw), Jacek Legutko (Krakow),, Janina Stępińska (Warsaw)
Panel: Jarosław Wójcik (Lublin), Mariusz Gąsior (Zabrze), Soon Jun Hong (Seoul), Bagrat Alyekan, (Moscow), Gary Mintz (New York), Shaoliang Chen (Nanjing), Andrzej Ochała (Katowice), Ivo Petrov (Sofia), Piotr Suwalski (Warsaw)

9:00-9:40 Live case 1. Patient with NSTE-ACS and multivessel CAD.
Operators: Marek Grygier (Poznań), Tomasz Pawłowski (Warsaw)
FFR/IVUS/OCT: Sławomir Gołębiewski (Warsaw)

Featured Lectures
• 9:40-9:55 NSTE-ACS: risk assessment and outcomes. Marek Gierlotka (Zabrze)
• 9:55-10:10 NSTE-ACS: Platelet inhibition and anticoagulation. Bela Merkely (Budapest)

10:10-10:50 Live case 2. Patient with NSTE-ACS and left main stenosis.
Operators: Maciej Lesiak (Poznań), Sławomir Gołębiewski (Warsaw)
FFR/IVUS/OCT: Tomasz Pawłowski (Warsaw)

Featured Lecture:
• 10:50-11:05 Percutaneous coronary intervention and coronary artery bypass surgery in NSTE-ACS. Adam Witkowski (Warsaw)

11:05-11:30 ROOM C
Acute coronary syndrome: case presentations.
Chairmen: Ralf Birkemeyer (Ulm), Dariusz Dudek (Krakow), Mariusz Gąsior (Zabrze)
Panelists: Marek Dąbrowski (Warsaw), Sławomir Dobrzycki (Bialystok), Robert J. Gil (Warsaw), Krzysztof Kuśmierski (Warsaw), Jacek Legutko (Krakow), Krzysztof Reczuch (Wrocław), Janusz Rzeźniczak (Poznań)

• 11:05-11:10 Case 1. Young Joon Hong (Kwanju)
• 11:10-11:13 Discussion
• 11:13-11:23 Case 2. Lucian Zarma (Bucharest)
• 11:23-11:26 Discussion
• 11:26-11:36 Case 3. Jan Jastrzębski (Warsaw)
• 11:36-11:40 Discussion

11:40-12:20 ROOM C
Opening Ceremony.
1. Robert J. Gil and Adam Witkowski, WCCI Directors
2. Piotr Hoffman, President of the Polish Cardiac Society
3. Andreas Baumbach, Secretary of the European Association of Percutaneous Cardiovascular Interventions
4. William Wijns, Chairman of PCR
5. ANDREAS AWARD

12:20-12:30 COFFEE BREAK

12:30-16:55 ROOM A+B
Learning Pathway on Multivessel Coronary Artery Disease.

PCR SESSION @ WCCI
12:30-14:30 PCI in complex Multivessel Coronary Artery Disease.
Facilitators: Andreas Baumbach (Bristol), Robert J. Gil (Warsaw), Goran Stankovic (Belgrade)
Media Driver: Mariusz Kłopotowski (Warsaw)

Live-in-a box cases 1 and 2

14:30-15:30 LUNCH

14:30-15:00 BOARDROOM
Advances in the Interventional Cardiology. Editorial Board Meeting.

PCR SESSION @ WCCI
15:30-17:00 ROOM A+B
How Should I treat complex Multivessel Coronary Artery Disease?
Chairmen: Andrzej Ochała (Katowice), William Wijns (Aalst), Adam Witkowski (Warsaw)
2 invited cases presented and disscussed
Experts (1st case): Andreas Baumbach (Bristol), Goran Stankovic (Belgrade),
Experts (2nd case): Ravi Nair (Cleveland/Abu Dhabi), Jacek Legutko (Krakow)
Consensus after each case will be delivered by the chairmen.

• 15:30-15:35 Introduction and objectives. William Wijns (Aalst)

15:35-16:15 Case 1.
Speaker 1: Case presentation. Sung Yun Lee (Seoul)
Expert 1: How would I treat? Andreas Baumbach (Bristol)) – 7 minutes
Expert 2: How would I treat?– Goran Stankovic (Belgrade 7 minutes
Speaker 1: How did I treat. Sung Yun Lee (Seoul) – 5 minutes
Discussion – 10 minutes
Consensus: Andrzej Ochała (Katowice) – 5 minutes

16:15-16:55 Case 2.
Speaker 2: Case presentation. Tomasz Roleder (Katowice) – 5 minutes
Expert 1: How would I treat? Ravi Nair (Cleveland/Abu Dhabi) – 7 minutes
Expert 2: How would I treat? Jacek Legutko (Krakow) – 7 minutes
Speaker 2: How did I treat. Tomasz Roleder (Katowice) – 5 minutes
Discussion – 10 minutes
Consensus: Adam Witkowski (Warsaw) – 5 minutes

12:30-17:00 ROOM C
Learning Pathway on Carotid Stenting

PCR SESSION @ WCCI
12:30-14:30 ROOM C
Pathway on Carotid Stenting.
Facilitators: Piotr Musiałek (Krakow), Antoine Sauguet (Toulouse)
Media Driver: Mikołaj Kosek (Warsaw)

Live in a box case 3 and 4.

14:30-15:30 LUNCH

PCR SESSION @ WCCI
15:30-16:55 ROOM C
How Should I Treat Carotid Stenosis?
Chairmen: Zbigniew Chmielak (Warsaw), Piotr Pieniążek (Krakow), Antoine Sauguet (Toulouse)
2 invited cases presented and disscussed
Experts (1st case): Tomasz Jargiełło (Lublin), Piotr Musiałek (Krakow)
Experts (2nd case): Rafał Maciąg (Warsaw), Stanisław Bartuś (Krakow)
• 15:30-15:35 Introduction and objectives. Antoine Sauguet (Toulouse)

15:35-16:15 Case 1.
Speaker 1: Case presentation. Włodzimierz Skorupski (Poznań) – 5 minutes
Expert 1: How would I treat? Tomasz Jargiełło (Lublin) – 7 minutes
Expert 2: How would I treat? Piotr Musiałek (Krakow) – 7 minutes
Speaker 1: How did I treat. Włodzimierz Skorupski (Poznań) – 5 minutes
Discussion – 10 minutes
Consensus: Piotr Pieniążek (Krakow) – 5 minutes

16:15-16:55 Case 2.
Speaker 2: Case presentation. Marek Świerad (Zabrze) – 5 minutes
Expert 1: How would I treat? Rafał Maciąg (Warsaw) – 7 minutes
Expert 2: How would I treat? Stanisław Bartuś (Krakow) – 7 minutes
Speaker 2: How did I treat. Marek Świerad (Zabrze) – 5 minutes
Discussion – 10 minutes
Consensus: Zbigniew Chmielak (Warsaw) – 5 minutes

17:00-17:20 COFFEE BREAK

17:20-19:45 ROOM A+B
Non-ST Segment Elevation Acute Coronary Syndromes: Revascularization in the perspective of growing elderly patients population in Europe.

EAPCI @ WCCI Session
Chairmen: Paweł Buszman (Ustron), Marek A. Deja (Katowice), William Wijns (Aalst)
Experts: Andreas Baumbach (Bristol), Bela Merkely (Budapest),  Mariusz Gąsior (Zabrze),  Robert J. Gil (Warsaw), Petr Kala (Brno), Sang-Wook Kim (Seoul), Ahmed Magdy (Cairo), Andrzej Wnęk (Sieradz)
• 17:20-17:25 Learning objectives. Adam Witkowski (Warsaw)

17:25-18:05 Live case 3. An elderly patient with advanced multivessel coronary artery disease. Role of ROTA.
Operators: Dobrzycki (Białystok), Tomasz Pawłowski (Warsaw)
FFR/IVUS/OCT: Sławomir Gołębiewski (Warsaw)
• 18:05-18:20 State-of the-art lecture: How new ESC guidelines on NSTE-ACS and growing elderly patient population impacts daily practice in Europe? Dariusz Dudek (Krakow)

18:20-19:00 Live case 4. A patient with left main disease. Hungarian experience from Budapest
Operators: TBD

19:00-19:40 Live case 5. A patient with multivessel coronary artery disease. Czech experience from Brno.
Operators: TBD

• 19:40-19:45 Take-home message. Marek A. Deja (Katowice)

17:20-18:40 ROOM C
Concurrent WCCI session. Forum on transcather aortic valve implantation: case review.
Chairmen: Anson Cheung (Vancouver), Marek Jasiński (Katowice), Lars Sondergaard (Copenhagen)
Panelists: Marek Grygier (Poznan), Janusz Kochman (Warszawa), Radosław Parma (Katowice), Jan Z. Peruga (Łódź), Krzysztof Wilczek (Zabrze), Bagrat Alekyan (Moscow)

• 17:20-17:25 Learning objectives. Lars Sondergaard (Copenhagen)
• 17:25-17-30 Case 1. Marek Grygier (Poznan)
• 17:30-17:35 Discussion
• 17:35-17:45 Case 2. Maciej Dąbrowski (Warsaw)
• 17:45-17:50 Discussion
• 17:50-18:00 Case 3. Ralf Birkemeyer (Ulm)
• 18:00-18:05 Discussion
• 18:05-18:15: Case 4. Dariusz Jagielak (Gdańsk)
• 18:15-18:20 Discussion
• 18:20-18:30 Case 5. Krzysztof Reczuch (Wrocław)
• 18:30-18:35 Discussion
• 18:35-18:40 Take-home message. Marek Jasiński (Katowice)

9:00-19:00 AIDA ROOM
Medtronic Innovation Village

9:00-11:06 ROOM A
SESSION 1. Expanding experience with left atrial appendage occlusion (LAAO).
Chairmen: Marcin Demkow (Warsaw), Marek Grygier (Poznań), David Meerkin (Jerusalem)
Panelists: Janusz Kochman (Warsaw), Pawel Kralisz (Białystok), Tomasz Pawłowski (Warsaw), Krzysztof Reczuch (Wrocław), Janusz Rzeźniczak (Poznań), Janusz Sławin (Wrocław)

• 9:00-9:12 New Guidelines and Recommendations for LAAO. Jai-Wun Park (Koburg)
• 9:12-9:24 How do I select my patients? – Scientific evidence and current clinical practice in Europe. Grzegorz Smolka (Katowice)
• 9:24-9:36 How do I plan and perform my procedure? – Tips and tricks for safe and successful device implantation. Jai-Wun Park (Koburg)
• 9:36-9:45 Discussion
• 9:45-10:25 Life case 1: LAAO with Watchman
Operators: Saibal Kar (Los Angeles), Radosław Pracoń (Warsaw)
ECHO: Marek Konka (Warsaw)
• 10:25-10:37 How do I follow-up my patients after LAAO? – Optimal pharmacologic treatment strategies and post-procedural imaging. David Meerkin (Jerusalem)
• 10:37-10:49 LAAO with ACP Amulet device guided by 3D-printed personalized heart model. Sebastian Bujak (Warsaw)
• 10:49-11:01 Thrombus on LAA occluder: What is the risk of complications? How to treat? Cezary Kępka (Warsaw)
• 11:01-11:06 Take-home message. Marek Grygier (Poznan)

9:00-11:17 ROOM B
SESSION 2. Carotid, vertebral and subclavian artery revascularization.
Chairmen: Tomasz Jargiełło (Lublin), Wacław Kuczmik (Katowice), Andrzej Ochała (Katowice), Piotr Pruszczyk (Warsaw)
Panelists: Stanisław Bartuś (Krakow), Tomasz Deptuch (Józefów), Sławomir Dobrzycki (Białystok), Tadeusz Przewłocki (Krakow), Wlodzimierz Skorupski (Poznań), Jarosław Wójcik (Lublin), Dobrin Vassiliev (Sofia). Lucian Zarma (Bucharest), Hoyoun Won (Seoul)

• 9:00-9:24 Debate: Optimal carotid revascularization
• 9:00-9:12 Carotid endarterectomy is the treatment of choice in majority if patients. Wacław Kuczmik (Katowice)
• 9:12-9:24 Carotid stenting is the treatment of choice in majority of patients. Antoine Sauguet (Toulouse)
• 9:24-9:30 Discussion

• 9:30-10:10 Life case 2: Carotid stenting.
Operators: Marek Świerad (Zabrze), Zbigniew Chmielak (Warsaw)
• 10:10-10:22 Transradial approach for carotid stenting. Piotr Pieniążek (Krakow)
• 10:22-10:34 Vertebral artery angioplasty: patient selection and technique. Włodzimierz Skorupski (Poznań)
• 10:34-10:46 Subclavian artery angioplasty: when it is really needed? Tadeusz Przewłocki (Krakow)
• 10:46-11:00 Discussion

Featured lecture:
• 11:00-11:12 Multimodal approach to treat lesions in patients with non-operable distal chronic thromboembolic pulmonary hypertension. Marek Roik (Warsaw)
• 11:12-11:17 Take-home message. Andrzej Ochała

9:00-11:15 ROOM C
SESSION 3. Transcatheter valve-in-valve interventions: the gold standard treatment for bioprosthetic failure?
Chairmen: Magnus Settergren (Solna), Tomasz Hryniewiecki (Warsaw), Bernard Prendergast (London)

Panelists: Maciej Dąbrowski (Warsaw), Marek A. Deja (Katowice), Ariel Finkelstein (Tel Aviv), Tomasz Hirnle (Białystok), Krzysztof Kuśmierski (Warsaw), Arkadiusz Pietrasik (Warsaw), Jerzy Pręgowski (Warsaw), Tomasz Siminiak (Poznań), Adam Sukiennik (Bydgoszcz)

• 9:00-9:12 What have we learned from the international registries of transcatheter valve-in-valve implantations? Dariusz Dudek (Krakow)
• 9:12-9:24 The role of noninvasive imaging for patient selection and procedural guidance. Piotr Szymański (Warsaw)
• 9:24-9:36 Valve-in-valve/valve-in-ring in the tricuspid position. Marcin Demkow (Warsaw)
• 9:36-9:48 Valve-in-valve in the pulmonary position. Stephan Schubert (Berlin)
• 9:48-10:00 Valve-in-valve/valve-in-ring  in the mitral position. Lars Sondergaard (Copenhagen)
• 10:00-10:12 Valve-in-valve in the aortic position. Marek Grygier (Poznań)
• 10:12-10:32 Live-in-a box 1: Transcatheter valve-in-valve
• 10:32-10:45 Discussion
• 10:45-10:50 Take-home message. Bernard Prendergast (London)

FEATURED LECTURES:
• 10:50-11:03 Overview of the currently available transcatheter mitral valve repair devices and results of the trials. Magnus Settergren (Solna)
• 11:02-11:15 Transcatheter mitral valve replacement: new valves and experiences. Lars Sondergaard (Copenhagen)

11:05-11:30 COFFEE BREAK

11:30-13:10 ROOM A
SESSION 4. TAVI: Going Ahead (part 1)
Chairmen: Andreas Baumbach (Bristol), Ariel Finkelstein (Tel Aviv), Witold Rużyłło (Warsaw)

Panelists: Marco Brabanti (Catania), Ralf Birkemeyer (Ulm), Sławomir Dobrzycki (Białystok),  Dariusz Dudek (Krakow), Eberhardt Grube (Bonn), Janusz Kochman (Warsaw), Krzysztof Reczuch (Wrocław)
• 11:30-11:42 TAVI for intermediate risk patients – It’s about time! Ariel Finkelstein (Tel Aviv)
• 11:42-11:54 Brain protection in TAVI – Ready for prime time? Andreas Baumbach (Bristol)
• 11:54-12:06 Clinical experience with SAPIEN 3. Bernard Prenedrgast (London)
• 12:06-12:18 Clinical experience with EVOLUTE R. Eberhardt Grube (Bonn)
• 12:18-12:30 Clinical experience with LOTUS. Marco Brabanti (Catania)
• 12:30-12:42 Clinical experience with NVT TAVI System. Janusz Kochman (Warsaw)
• 12:42-13:20 Live case 3: TAVI with LOTUS valve.
Operators: Adam Witkowski (Warsaw), Maciej Dąbrowski (Warsaw), Jan Harnek (Lund)
ECHO: Patrycjusz Stokłosa (Warsaw)

11:30-13:00 ROOM B
SESSION 5. Hybrid strategies for  cardiac diseases. Best of two worlds – Cardiology and Cardiac Surgery.
Chairmen: Bagrat Alekyan (Moscow), Piotr Suwalski (Warsaw), Nikolaos Bonaros (Innsbruck)
Panelists: Mariusz Gąsior (Zabrze), Tomasz Hirnle (Białystok), Adam Kern (Olsztyn), Maciej Karcz (Warsaw), Maciej Lesiak (Poznań), Jarosław Zalewski (Kraków)

• 11:30-11:40 Scope of the problem. Jarosław Zalewski (Krakow)
• 11:40-11:55 Hybrid treatment of  multivessel coronary disease – in whom and how? Mateusz Tajstra (Zabrze)
• 11:55-12:15 Live-in-a box 2: Hybrid  coronary revascularization in MVD (EACAB plus PCI).
Operators:   Robert J. Gil (Warsaw), Piotr Suwalski (Warsaw)
• 12.15-12.30„Best of two worlds”  in the hybrid  treatment of arrhythmias.  Piotr Suwalski (Warsaw)
• 12:30-12:45 Rationale for Hybrid Approach using minimally invasive valve surgery and PCI in complex patients. Marek A. Deja (Katowice)
• 12:45-12:55 Discussion.
• 12:55-13:00 Take home message. Nicolas Bonaros (Insbruck)

11:30-13:00 ROOM C
SESSION 6. Role of intracoronary diagnostic methods in contemporary cathlabs. Guidelines versus reality.
Chairmen: Shaoliang Chen (Nanjing), Ravi Nair (Cleveleand/Abu Dhabi), Francesco Prati (Rome)

Panelists: So Yeon Choi (Seoul), Tomasz Pawłowski (Warsaw), Ivo Petrov (Sofia), Pranas Serpytis (Vilnus),Dobrin Vassiliev (Sofia), Vasil Velchev (Sofia), Wojciech Wojakowski (Katowice), Lucian Zarma (Bucharest)

• 11:30-12:10 Live case 4: PCI in a patient with multivessel CAD and LMS stenosis.
Operators: Jacek Legutko (Krakow), Jerzy Pręgowski (Warsaw)
IVUS/OCT/FFR: Paweł Tyczyński, Łukasz Kalińczuk (Warsaw)
• 12:10-12:22 Physiological coronary lesions assessment. Elvin Kehdi (Zwolle)
• 12:22-12:36 Visual assessment: OCT vs IVUS vs IVUS HD. Francesco Prati (Rome)
• 12:36-12:48 Combined mehods: FFR+ID, FFR + IVUS, NIRS. Wojciech Wojakowski (Katowice)
• 12:48-12:55 Discussion
• 12:55-13:00 Take-home message. Francesco Prati (Rome)

13:00-13:15 COFFEE BREAK

13:15-14:15 ROOM A
Luncheon Session 1.
Sponsored by unrestricted grant by TERUMO. Minimizing the risk of complex coronary intervention.
Moderators: Jarosław Wójcik (Lublin)
1. Overcoming obstacles in complex coronary intervention with radial approach. TBD
2. Coronary intervention in STEMI – fast, safe and effective! Tomasz Pawłowski
3. Complex bifurcation stenting in 2016 – staying on a safe side! Maciej Lesiak
4. Transradial approach for coronary chronic total occlusion – when and how? Jarosław Wójcik
5. Efficiency and safety during transradial approach in endovascular procedures. Sławomir Dobrzycki.

14:15-14:30 COFFEE BREAK

14:30-15:55 ROOM A
SESSION 8. TAVI: Going Ahead (part 2)
Chairmen: Jan Harnek (Lund), Zbigniew Chmielak (Warsaw), Lars Sondergaard (Copenhagen)

Panelists: Andreas Baumbach (Bristol), Tomasz Hirnle (Białystok), Dariusz Jagielak (Gdańsk), Krzysztof Reczuch (Wrocław), Łukasz Tułecki (Zamość)

• 14:30-14:40 What should still be addressed to assure safety and effecivness in TAVI? Adam Witkowski (Warsaw)
• 14:40-14:52 New technology platforms for TAVI. Saibal Kar (Los Angeles)
• 14:52-15:04 Perivalvular leaks – still a concern in TAVI? Ralf Birkemeyer (Ulm)
• 15:04-15:16 Avoiding of bleedings and vascular complications. Marek Grygier (Poznań)
• 15:16-15:28 Advantages of transapical approach for TAVI. Piotr Olszówka (Rzeszów)
• 15:28-15:40 Advantages of transfemoral approach for TAVI. Sławomir Dobrzycki (Białystok)
• 15:40-15:50 Discussion
• 15:50-15:55 Take-home message. Jan Harnek (Lund)

14:30-16:30 ROOM B
SESSION 7. Bioresobable coronary scaffolds: clinical evidence from trials and registries versus reality.
Chairmen: Dariusz Dudek (Krakow), Michael Haude (Neuss), Maciej Lesiak (Poznań)
Panelists: Shaoliang Chen (Nanjing), Andrzej Lekston (Zabrze), Robert J. Gil (Warsaw), Young Joon Hong (Gwangju),  Jerzy Pręgowski (Warsaw), Wojciech Wojakowski (Katowice)

• 14:30-14:42 What are the bioresorbable scaffolds and why we need them? Robert J. Gil (Warsaw)
• 14:42-14:57 Highlights from the ABSORB trials. Dariusz Dudek (Krakow)/Maciej Lesiak (Poznan)
• 14:57-15:09 Highlights from the DREAMS trials. Michael Haude (Neuss)
• 15:09-15:21 Highlights from the DESolve trials. Stylianos Pyxaras (Coburg)
• 15:21-16:00 Live case 5: Coronary revascularization with bioresorbable stents.
Operators: Krzysztof Kukuła (Warsaw), Artur Dębski (Warsaw)
IVUS/OCT/FFR: Paweł Tyczyński, Łukasz Kalińczuk (Warsaw)
• 16:00-16:12 Polish experience: real life use of bioresorbable scaffolds (Zabrze Registry). Michał Hawranek (Zabrze)

• 16:12-16:24 Featured Lecture.
Patients treated with bivalirudin still at higher risk of stent thrombosis: a comprehensive meta-analysis of randomized clinical trials of bivalirudin and heparin for percutaneous coronary interventions. Stefan Grajek (Poznan)
• 16:24-16:30 Take-home message. Maciej Lesiak (Poznań)

14:30-16:05 ROOM C
SESSION 8. A Patient with ischemic heart disease and angiographically normal coronary arteries. How to manage ?
Chairmen: Robert J. Gil, Elvin Kehdi (Zwolle), Giuseppe De Luca (Novara), Sang-Wook Kim (Seoul), Ahmed Magdy (Cairo)

Panellists: Ricardo Costa (Sao Paulo), Jacek Kądziela (Warsaw), Jacek Legutko (Krakow), Tomasz Pawłowski (Warsaw), Francesco Prati (Rome), Tomasz Roleder (Katowice), Krzysztof Milewski (Warsaw)

• 14:30-14:35 Scope of the problem. Krzysztof Milewski (Warsaw)
• 14:35-14:47 Myocardial bridge, vasospastic angina, microvascular angina, and others – prevalence and mechanisms. Tomasz Pawłowski (Warsaw)
• 14:47-14:59 Myocardial infarction in non-obstructive coronary arteries (MINOCA) – what is it and how to deal with. Jacek Bil (Warsaw)
• 14.59-15:11 The role of imaging modalities (IVUS, OCT, CMR, CT) and provocative tests in diagnosis of IHD with angiographically normal arteries. Jacek Legutko (Krakow)
• 15.11-15.23 Prognosis and optimal treatment in pts with IHD and angiographically normal coronaries. Michał Hawranek (Zabrze)
• 15.23-16.00 Live-in-a box 3: PT with IHD and with angiographically normal coronaries diagnosed with: IVUS, OCT and ID + Acetylocholine test. Jacek Bill (Warsaw), Tomasz Pawłowski (Warsaw)
• 16.00-16.05 Take home message. Giuseppe De Luca (Novara)

9:00-14:00 AIDA ROOM:
Medtronic Innovation Village